Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Latest filing published 06 Mar 2023 for Sesen Bio, Inc., €85k.
Filing timeline
BuySaleMonica Forbes
Insider track record
Disclosed buys
0
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Monica Forbes: trading record in brief
Monica Forbes (finance chief) discloses dealings in Sesen Bio, Inc. to SEC (Form 4). Over a trading history stretching from 18 February 2022 to 2 March 2023, the count stands at 7 filings.
Sales make up the whole of the open-market record (4 sales, €224k). Besides market trades, the filings include 1 share grant and 2 option exercises. So far in 2023, the count stands at no purchases and 4 sales.
On 6 March 2023 came the latest disclosure, an option exercise for €105k in Sesen Bio, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Monica Forbes
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
154,266 shares@ US$0.58771.4% of flowCommon StockSEC:0001485003-23-000103:0
61,862 shares@ US$0.587328.6% of flowCommon StockSEC:0001485003-23-000060:0
542,250 shares0Common StockSEC:0001485003-22-000019:0
3 of 3 declarations
